
浏览全部资源
扫码关注微信
1.山东中医药大学 第一临床医学院,济南 250014
2.山东中医药大学 附属医院,济南 250014
潘静,在读博士,从事月经病与不孕症的中医药研究,E-mail:2233697678@qq.com
于潇,博士,从事月经病、不孕症、盆腔炎性疾病后遗症等的中医药治疗研究,E-mail:xiao675364548@163.com;
张建伟,教授,博士生导师,主任医师,从事中医药在生殖医学中的应用及月经病的中医药研究,E-mail:zhangjianwei1970@sina.com
收稿日期:2022-10-20,
网络出版日期:2023-02-10,
纸质出版日期:2023-05-20
移动端阅览
潘静,刘鹏飞,刘金星等.启宫丸对痰湿证PCOS不孕患者卵子质量和胚胎发育潜能的影响[J].中国实验方剂学杂志,2023,29(10):152-159.
PAN Jing,LIU Pengfei,LIU Jinxing,et al.Effect of Qigongwan on Quality of Oocytes and Embryonic Development Potential in Patients with PCOS Infertility with Phlegm-dampness Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(10):152-159.
潘静,刘鹏飞,刘金星等.启宫丸对痰湿证PCOS不孕患者卵子质量和胚胎发育潜能的影响[J].中国实验方剂学杂志,2023,29(10):152-159. DOI: 10.13422/j.cnki.syfjx.20231591.
PAN Jing,LIU Pengfei,LIU Jinxing,et al.Effect of Qigongwan on Quality of Oocytes and Embryonic Development Potential in Patients with PCOS Infertility with Phlegm-dampness Syndrome[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(10):152-159. DOI: 10.13422/j.cnki.syfjx.20231591.
目的
2
观察启宫丸对痰湿证多囊卵巢综合征(PCOS)不孕患者卵泡颗粒细胞(GCs)中增殖与凋亡相关因子程序性细胞死亡蛋白4(PDCD4)和增殖细胞核抗原(PCNA)表达的调控,探讨启宫丸对卵子质量和胚胎发育潜能的影响。
方法
2
选取行体外受精-胚胎移植(IVF-ET)的痰湿证PCOS患者66例,按照随机数字表法分为观察组(启宫丸+西药)和对照组(西药),每组33例,均行拮抗剂方案促排卵。观察组于IVF前1周期始在服用西药的基础上联合启宫丸进行治疗,对照组则不予中药干预。观察两组患者痰湿证候改善、促性腺激素(Gn)使用天数和用量、注射人绒毛促性腺激素(HCG)日血清黄体生成素(LH)、雌二醇(E
2
)、孕酮(P)水平、双原核(2PN)受精率和优质胚胎率。实时荧光定量聚合酶链式反应(Real-time PCR)及蛋白免疫印迹法(Western blot)检测GCs中PDCD4和PCNA的表达。
结果
2
与本组治疗前比较,两组患者痰湿证候评分均显著降低(
P
<
0.01);与对照组治疗后比较,观察组痰湿证候评分降低更明显,差异具有统计学意义(
P
<
0.01)。与对照组比较,观察组HCG日血清LH、E
2
和P水平均升高,但只有E
2
水平差异有统计学意义(
P
<
0.01);观察组2PN受精率[82.25%(556/676)/69.92%(365/522),
χ
2
=25.172,
P
<
0.01]和优质胚胎率[44.19%(190/430)/34.23%(102/298),
χ
2
=7.266,
P
<
0.01]均显著升高,差异具有统计学意义(
P
<
0.01);观察组卵巢GCs中PDCD4 mRNA和蛋白表达量均下调,PCNA mRNA和蛋白表达量均上调,差异均有统计学意义(
P
<
0.05)。
结论
2
启宫丸可能通过下调PDCD4的表达和上调PCNA的表达来干预卵泡发育过程,调节激素水平,改善痰湿证PCOS患者证候表现,抑制GCs凋亡并促进生长,以改善卵子质量和胚胎发育潜能。
Objective
2
To observe the regulation of Qigongwan on the expression of proliferation and apoptosis-related factors programmed cell death 4 (PDCD4) and proliferating cell nuclear antigen (PCNA) in ovarian granulosa cells (GCs) in patients with polycystie ovarian syndrome (PCOS) infertility with phlegm-dampness syndrome, and to explore the effect of Qigongwan on the quality of oocytes and embryonic development potential.
Method
2
Sixty-six patients with PCOS with phlegm-dampness syndrome who underwent
in vitro
fertilization and embryo transfer (IVF-ET) were randomly selected and divided into an observation group (Qigongwan + western medicine) and a control group (western medicine), with 33 patients in each group. Antagonist regimen was used to promote ovulation in the two groups. The observation group was given Qigongwan one cycle before IVF based on the treatment of conventional western medicine, while the control group was not given Chinese medicine. The improvement of phlegm and dampness syndrome, the dosage and the number of days of using gonadotropins (Gn), the levels of luteinizing hormone (LH), estradiol (E
2
), and progesterone (P) on the day of human chorionic gonadotropin(HCG) injection, the 2PN fertilization rate, and the high-quality embryo rate of patients in the two groups were compared. Real-time polymerase chain reaction (Real-time PCR) and Western blot technology were used to detect the expression of PCNA and PDCD4 in GCs.
Result
2
As compared with groups before treatment, the score of phlegm-dampness syndrome in both groups was significantly lower (
P
<
0.01). The score of phlegm and dampness syndrome in the observation group was significantly lower than that of the control group (
P
<
0.01). As compared with the control group, the levels of LH, E
2
, and P in the observation group was higher, but only the difference in the level of E
2
was statistically significant (
P
<
0.01). The 2PN fertilization rate [82.25% (556/676)
vs
69.92% (365/522),
χ
2
=25.172,
P
<
0.01] and high-quality embryo rate [44.19% (190/430)
vs
34.23% (102/298),
χ
2
=7.266,
P
<
0.01] in the observation group were significantly higher than that of the control group (
P
<
0.01). As compared with the control group, the mRNA and protein expression of PDCD4 in ovarian GCs was down-regulated in the observation group and that of PCNA was up-regulated (
P
<
0.05).
Conclusion
2
By down-regulating the expression of PDCD4 and up-regulating the expression of PCNA, Qigongwan may interfere with follicle development, adjust hormone levels, improve the symptomatic manifestations of patients with PCOS with phlegm-dampness syndrome, inhibit the apoptosis of GCs, and promote growth, thus improving the quality of oocytes and embryonic development potential.
ORTIZ-FLORES A E , LUQUE-RAMíREZ M , ESCOBAR-MORREALE H F . Polycystic ovary syndrome in adult women [J]. Med Clin (Barc) , 2019 , 152 ( 11 ): 450 - 457 .
LI X , DING W , LIU J Y , et al . Effects of dyslipidemia on IVF/ICSI pregnancy outcome in patients with polycystic ovary syndrome [J]. Chin J Obstet Gynecol , 2018 , 53 ( 6 ): 402 - 408 .
张莉莉 , 赵红玉 , 王超颖 , 等 . 基于“因子分析”探讨多囊卵巢综合征(排卵障碍)的证候要素分布 [J]. 世界中西医结合杂志 , 2020 , 15 ( 7 ): 1211 - 1214 .
李丹妮 . 不同BMI多囊卵巢综合征患者内分泌代谢特征及中医证候分布研究 [D]. 天津 : 天津中医药大学 , 2020 .
吕文君 . 启宫丸加减治疗多囊卵巢综合征的疗效 [J]. 实用妇科内分泌电子杂志 , 2019 , 6 ( 21 ): 110 , 116 .
陈姗姗 , 张宁 . 启宫丸在痰湿型多囊卵巢综合征患者行IVF-ET中的应用价值 [J]. 中医药通报 , 2017 , 16 ( 5 ): 28 - 29,14 .
谢幸 , 孔北华 , 段涛 . 妇产科学 [M]. 9版 . 北京 : 人民卫生出版社 , 2018 : 361 .
谈勇 . 中医妇科学 [M]. 4版 . 北京 : 中国中医药出版社 , 2016 : 250 - 251 .
Brinsden P R . A Textbook of in vitro fertilization and assisted reproduction [M]. New York : The Parthenon Publishing Group Inc , 1999 .
陈修园 . 女科要旨 [M]. 福州 : 福建科学技术出版社 , 1982 : 74 .
朱震亨 . 丹溪心法 [M]. 北京 : 人民卫生出版社 , 2005 : 57 - 60 .
张萍 , 王维斌 , 邵岩飞 , 等 . 二陈汤对多囊卵巢综合征大鼠卵巢组织Bcl-2及Bax蛋白表达的影响 [J]. 北京中医药大学学报 , 2020 , 43 ( 11 ): 941 - 950 .
崔文娜 . 苍附导痰汤对痰湿型PCOS患者卵巢颗粒细胞脂联素受体基因的表达及妊娠结局的影响 [D]. 济南 : 山东中医药大学 , 2019 .
赵帅 , 连方 , 吴海萃 . 苍附导痰颗粒对痰湿证多囊卵巢综合征患者卵巢颗粒细胞基因表达干预的研究 [J]. 中国中西医结合杂志 , 2021 , 41 ( 2 ): 177 - 183 .
KYROU D , POPOVIC-TODOROVIC B , FATEMI H M , et al . Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? [J]. Hum Reprod , 2009 , 24 ( 11 ): 2902 - 2909 .
张馨怡 , 谭季春 . 多囊卵巢综合征中卵巢颗粒细胞的研究进展 [J]. 中国实用妇科与产科杂志 , 2019 , 35 ( 1 ): 134 - 136 .
KWON C Y , CHO I H , PARK K S . Therapeutic effects and mechanisms of herbal medicines for treating polycystic ovary syndrome:A review [J]. Front Pharmacol , 2020 , 11 : 1192 .
吴坚 , 郑赓唐 , 张琳 , 等 . 多囊卵巢综合征卵巢颗粒细胞凋亡调控蛋白Bcl-2、Bax、p53的表达及其意义 [J]. 新医学 , 2019 , 50 ( 7 ): 536 - 539 .
范从红 , 李根 , 廖晓燕 , 等 . 二甲双胍对多囊卵巢综合征大鼠排卵及卵巢颗粒细胞中B淋巴细胞瘤-2和兔抗人单克隆抗体表达的影响 [J]. 中国妇幼保健 , 2017 , 32 ( 24 ): 6277 - 6281 .
QIU X , WEI Y , LIU C , et al . Hyperandrogen enhances apoptosis of human ovarian granulosa cells via up-regulation and demethylation of PDCD4 [J]. Gynecol Endocrinol , 2020 , 36 ( 4 ): 333 - 337 .
DING L , GAO F , ZHANG M , et al . Higher PDCD4 expression is associated with obesity,insulin resistance,lipid metabolism disorders,and granulosa cell apoptosis in polycystic ovary syndrome [J]. Fertil Steril , 2016 , 105 ( 5 ): 1330 - 1337 .
FU X , HE Y , WANG X , et al . MicroRNA-16 promotes ovarian granulosa cell proliferation and suppresses apoptosis through targeting PDCD4 in polycystic ovarian syndrome [J]. Cell Physiol Biochem , 2018 , 48 ( 2 ): 670 - 682 .
李红娟 , 唐小珂 , 王雅莉 . 微RNA-21-5p靶向PDCD4基因对多囊卵巢综合征大鼠卵巢颗粒细胞增殖、凋亡的影响及其分子机制研究 [J]. 中华生物医学工程杂志 , 2019 , 25 ( 4 ): 450 - 454 .
LU J , XUE Y , WANG Y , et al . CiRS-126 inhibits proliferation of ovarian granulosa cells through targeting the miR-21-PDCD4-ROS axis in a polycystic ovarian syndrome model [J]. Cell Tissue Res , 2020 , 381 ( 1 ): 189 - 201 .
XIA H , ZHAO Y . miR-155 is high-expressed in polycystic ovarian syndrome and promotes cell proliferation and migration through targeting PDCD4 in KGN cells [J]. Artif Cells Nanomed Biotechnol , 2020 , 48 ( 1 ): 197 - 205 .
ZHAO Y , TAO M , WEI M , et al . Mesenchymal stem cells derived exosomal miR-323-3p promotes proliferation and inhibits apoptosis of cumulus cells in polycystic ovary syndrome (PCOS) [J]. Artif Cells Nanomed Biotechnol , 2019 , 47 ( 1 ): 3804 - 3813 .
WEI D , XIE J , YIN B , et al . Significantly lengthened telomere in granulosa cells from women with polycystic ovarian syndrome (PCOS) [J]. J Assist Reprod Genet , 2017 , 34 ( 7 ): 861 - 866 .
CHEN H , GUO J H , ZHANG X H , et al . Defective CFTR-regulated granulosa cell proliferation in polycystic ovarian syndrome [J]. Reproduction , 2015 , 149 ( 5 ): 393 - 401 .
ZHAO J , XU J , WANG W , et al . Corrigendum to "Long non-coding RNA LINC-01572:28 inhibits granulosa cell growth via a decrease in p27 (Kip1) degradation in patients with polycystic ovary syndrome" [EBioMedicine 36 (2018) 526-538] [J]. EBioMedicine , 2018 , 37 : 563 .
张国青 . MiRNA-21-3p在多囊卵巢综合征中的表达及其相关功能研究 [D]. 长春 : 吉林大学 , 2019 .
MUSKHELISHVILI L , WINGARD S K , LATENDRESSE J R . Proliferating cell nuclear antigen-A marker for ovarian follicle counts [J]. Toxicol Pathol , 2005 , 33 ( 3 ): 365 - 368 .
0
浏览量
30
下载量
3
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621